NCT04841460

Brief Summary

The primary goal of the proposed research is to document changes in plasma lipoprotein fractions, including high-density lipoprotein (HDL) and low-density lipoprotein (LDL) particle sizes and functionality, following the ground beef interventions. This specifically addresses the hypothesis that increasing the amount of fat in ground beef reduces risk factors for cardiovascular disease. Also, the investigators will measure changes in glucose, insulin, and triacylglycerols (TAG) following low-fat and high-fat ground beef interventions. An important aspect of this research is that the investigators will confirm that consumption of high-fat ground beef will reduce carbohydrate intake and increase insulin sensitivity in men. Furthermore, the investigators will be able to establish which protein sources are voluntarily replaced by the low- and high-fat ground beefs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 18, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 19, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2019

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

March 9, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 12, 2021

Completed
Last Updated

April 12, 2021

Status Verified

April 1, 2021

Enrollment Period

5 months

First QC Date

March 9, 2021

Last Update Submit

April 9, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Lipoprotein cholesterol

    Lipoprotein cholesterol concentrations and density distributions

    10 weeks

Secondary Outcomes (2)

  • Dietary intake

    10 weeks

  • Body mass index

    10 weeks

Study Arms (2)

Low-fat ground beef

EXPERIMENTAL

Participants will consume 25 low-fat ground beef patties, 5 patties per week for 5 weeks.

Dietary Supplement: Low-fat ground beef

High-fat ground beef

EXPERIMENTAL

Participants will consume 25 high-fat ground beef patties, 5 patties per week for 5 weeks.

Dietary Supplement: High-fat ground beef

Interventions

Low-fat ground beefDIETARY_SUPPLEMENT

5% fat ground beef

Low-fat ground beef
High-fat ground beefDIETARY_SUPPLEMENT

25% fat ground beef

High-fat ground beef

Eligibility Criteria

Sexmale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • The participants will be male and not have had total cholesterol above 300 mg/dL or below 120 mg/dL.

You may not qualify if:

  • The participants will be male and must not have been consuming restrictive diets or cholesterol-lowering medications.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Texas A&M University

College Station, Texas, 77843, United States

Location

Related Publications (1)

  • Gilmore LA, Walzem RL, Crouse SF, Smith DR, Adams TH, Vaidyanathan V, Cao X, Smith SB. Consumption of high-oleic acid ground beef increases HDL-cholesterol concentration but both high- and low-oleic acid ground beef decrease HDL particle diameter in normocholesterolemic men. J Nutr. 2011 Jun;141(6):1188-94. doi: 10.3945/jn.110.136085. Epub 2011 Apr 27.

Study Officials

  • Stephen B. Smith, Ph.D.

    Texas A&M University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Participant identities were coded and treatments were blinded.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: The study design is a two-period, randomized crossover design.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 9, 2021

First Posted

April 12, 2021

Study Start

February 18, 2019

Primary Completion

July 19, 2019

Study Completion

September 30, 2019

Last Updated

April 12, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Individual participant data may be shared with the funding agency.

Locations